Kenward Vong

9PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Chemical and thermal processes in energy and combustionTransition metal chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 23, 2026
Lectin-Directed Protein Aggregation Therapy toward Hyperfucosylated and Hypersialylated Metastatic Colorectal Cancers.

|Jun 10, 2026
Bioorthogonal Gold-Catalyzed Hydrothiolation Leading to Amide Bond Cleavage of Ethynylated Biarylbutanamide Precursors.

|Jan 30, 2026
Gold-Catalyzed Carbonyl Release and its Adaptation for Prodrug Therapy Using Multivalent Lectin-Directed Artificial Metalloenzymes.

Jing Huang, Yiling Liu, Yufei Li

|Jan 11, 2022
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression.

Igor Nasibullin, Ivan Smirnov, Peni Ahmadi

|Jun 07, 2021
Bioorthogonal release of anticancer drugs via gold-triggered 2-alkynylbenzamide cyclization.

Kenward Vong, Tomoya Yamamoto, Tsung-Che Chang

|Apr 24, 2021
Disrupting tumor onset and growth via selective cell tagging (SeCT) therapy.

Kenward Vong, Tsuyoshi Tahara, Sayaka Urano

Pageof 2

Frequent Collaborators

6 joint publications

Katsunori Tanaka

3 joint publications

Igor Nasibullin

2 joint publications

Jing Huang

1 joint publications

Yasuhiro Kadota